Target discovery and validation in pancreatic cancer.
暂无分享,去创建一个
[1] Tatiana Tatusova,et al. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..
[2] Tatiana A. Tatusova,et al. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..
[3] P. Kufer,et al. Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy , 2005, Cancer Immunology, Immunotherapy.
[4] Troels Z. Kristiansen,et al. Comprehensive proteomic analysis of human pancreatic juice. , 2004, Journal of proteome research.
[5] R. Hruban,et al. Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients , 2004, The Journal of experimental medicine.
[6] Narendra Tuteja,et al. Serial analysis of gene expression (SAGE): unraveling the bioinformatics tools. , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[7] Ira Pastan,et al. Mesothelin: a new target for immunotherapy. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] R. Hruban,et al. Pancreatic Intraepithelial Neoplasia , 2004, Pancreas.
[9] Christine A Iacobuzio-Donahue,et al. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. , 2004, American journal of clinical pathology.
[10] R. Hruban,et al. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] Christine A Iacobuzio-Donahue,et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. , 2003, Cancer research.
[12] Yutaka Shimada,et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours , 2003, Nature.
[13] R. Hruban,et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. , 2003, Cancer cell.
[14] Christine A Iacobuzio-Donahue,et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. , 2003, The American journal of pathology.
[15] David Botstein,et al. The Stanford Microarray Database: data access and quality assessment tools , 2003, Nucleic Acids Res..
[16] Juri Rappsilber,et al. Microcolumns with self-assembled particle frits for proteomics. , 2002, Journal of chromatography. A.
[17] R. Hruban,et al. An Introduction to Pancreatic Adenocarcinoma Genetics, Pathology and Therapy , 2002, Cancer biology & therapy.
[18] Kimberly Walter,et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. , 2002, The American journal of pathology.
[19] P. Hammel,et al. Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] K. Lillemoe,et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. , 2002, Cancer research.
[21] Ji Huang,et al. [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.
[22] C. Rosty,et al. Early detection of pancreatic carcinoma. , 2002, Hematology/oncology clinics of North America.
[23] Giovanni Parmigiani,et al. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. , 2002, Cancer research.
[24] J. Cameron,et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[25] J. Yates,et al. An automated multidimensional protein identification technology for shotgun proteomics. , 2001, Analytical chemistry.
[26] M. Löhr,et al. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. , 2001, Gastroenterology.
[27] G. Riggins,et al. Gene discovery using the serial analysis of gene expression technique: implications for cancer research. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J. Cameron,et al. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. , 2001, Cancer research.
[29] J. Yates,et al. Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.
[30] S. Altschul,et al. SAGEmap: a public gene expression resource. , 2000, Genome research.
[31] O. Vitolo,et al. Improved NlaIII digestion of PAGE-purified 102 bp ditags by addition of a single purification step in both the SAGE and microSAGE protocols. , 2000, Nucleic acids research.
[32] M. Mann,et al. Proteomics to study genes and genomes , 2000, Nature.
[33] R. Hruban,et al. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. , 2000, The American journal of pathology.
[34] A. Kassam,et al. Comprehensive transcript analysis in small quantities of mRNA by SAGE-lite. , 1999, Nucleic acids research.
[35] S. Altschul,et al. A public database for gene expression in human cancers. , 1999, Cancer research.
[36] N. Datson,et al. MicroSAGE: a modified procedure for serial analysis of gene expression in limited amounts of tissue. , 1999, Nucleic acids research.
[37] K. Mühlemann,et al. Substantially enhanced cloning efficiency of SAGE (Serial Analysis of Gene Expression) by adding a heating step to the original protocol. , 1999, Nucleic acids research.
[38] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[39] C. Moskaluk,et al. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. , 1997, Cancer research.
[40] P. Brown,et al. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. , 1996, Genome research.
[41] S. Goodman,et al. Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. , 1996, Human pathology.
[42] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[43] L. Penland,et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.
[44] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[45] R. Hruban,et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma , 1994, Nature Genetics.
[46] J. Eberwine,et al. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[47] P. Tarroux,et al. Improvement and simplification of low‐background silver staining of proteins by using sodium dithionite , 1988, Electrophoresis.
[48] V. Neuhoff,et al. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G‐250 and R‐250 , 1988, Electrophoresis.
[49] C. Merril,et al. A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. , 1979, Analytical biochemistry.